Physician

Clement K. Chan, M.D.

According to 2025 Medicare claims, Clement Chan, M.D. (NPI: 1336131408) practices ophthalmology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (NPI: 1962422709; TIN: 330303507) and primary practice location at 92211-6080.

Chan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 828 traditional Medicare patients, billed 39,169 HCPCS/CPT codes, and received $2,958,426 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,071 prescription claims across 166 beneficiaries totaling $57,698 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 28 records totaling $3,282. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $2,029,554 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,034,495 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,147,095 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,225,567 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,536,471 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,681,504 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,685,522 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,813,132 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,998,530 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,958,426 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157499,347$2,029,554
20167358,512$2,034,495
20177859,381$2,147,095
201879010,135$2,225,567
201980011,268$2,536,471
202072112,053$2,681,504
202178312,660$2,685,522
202287215,896$2,813,132
202383231,541$2,998,530
202482839,169$2,958,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$45K$90K2015 Drug cost: $89,901 (USD; Tot_Drug_Cst)2016 Drug cost: $86,268 (USD; Tot_Drug_Cst)2017 Drug cost: $56,022 (USD; Tot_Drug_Cst)2018 Drug cost: $62,357 (USD; Tot_Drug_Cst)2019 Drug cost: $71,929 (USD; Tot_Drug_Cst)2020 Drug cost: $68,279 (USD; Tot_Drug_Cst)2021 Drug cost: $71,566 (USD; Tot_Drug_Cst)2022 Drug cost: $57,635 (USD; Tot_Drug_Cst)2023 Drug cost: $70,762 (USD; Tot_Drug_Cst)2024 Drug cost: $57,698 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152771,343$89,901
20162721,518$86,268
20172221,062$56,022
20182221,129$62,357
20191831,018$71,929
2020167958$68,279
2021172922$71,566
2022149926$57,635
20231661,016$70,762
20241661,071$57,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1952,115$656
92014Established patient complete exam of visual system436712$104
67028Injection of drug into eye3501,774$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5731,448$66
92134Imaging of retina8102,567$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium301,695$13,082
Prednisolone AcetatePrednisolone Acetate1907,959$8,867
Bromfenac SodiumBromfenac Sodium15918$5,857
RhopressaNetarsudil Mesylate14579$4,113
Ketorolac TromethamineKetorolac Tromethamine1706,793$3,616

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$909Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$2,373Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Clement K. Chan, M.D.?

Tedicare shows public-source Medicare data for Clement K. Chan, M.D. (NPI 1336131408), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Clement K. Chan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Clement K. Chan, M.D.?

Clement K. Chan, M.D. is linked to PACIFIC EYE INSTITUTE, A MEDICAL GROUP, INC. (billing NPI 1962422709) in the available physician profile data.

Does Clement K. Chan, M.D. have Open Payments data?

Clement K. Chan, M.D. has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.